Deepa Prasad - 19 Oct 2021 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Reporting relationship: President and CEO, Director
Issuer ticker: VTVT
Reported as of: 19 Oct 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Oct 2021, 16:38:15 UTC
Prior SEC filing: 16 Jun 2021
Next SEC filing: 18 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Deepa Prasad

Key filing fact

Deepa Prasad filed Form 4 for vTv Therapeutics Inc. (VTVT) on 21 Oct 2021.

Key facts

This page summarizes Deepa Prasad's Form 4 filing for vTv Therapeutics Inc. (VTVT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 21 Oct 2021, 16:38.

Change

Previous filing in this sequence was filed on 16 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VTVT transaction Derivative

Employee stock option (right to buy)

Award

Transaction value: $0
Shares: +2,498,635
Change %
Price: $0.000000
Shares after: 2,498,635
Date: 19 Oct 2021
Ownership: Direct
Underlying class: Class A common stock
Underlying amount: 2,498,635
Exercise price: $1.47
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Options were granted as part of an inducement award and will vest on October 19, 2024 subject to continued employment (or earlier, upon achievement of certain performance measures).